BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 199 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,195,693 | +77.6% | 592,612 | +76.6% | 0.10% | +69.4% |
| Q2 2023 | $2,362,047 | +143.4% | 335,518 | +188.3% | 0.06% | +129.6% |
| Q1 2023 | $970,526 | -60.9% | 116,370 | -46.2% | 0.03% | -61.4% |
| Q4 2022 | $2,482,665 | +85.0% | 216,260 | +103.1% | 0.07% | +48.9% |
| Q3 2022 | $1,342,000 | +72.5% | 106,470 | +44.8% | 0.05% | +34.3% |
| Q2 2022 | $778,000 | -20.4% | 73,512 | +22.2% | 0.04% | -23.9% |
| Q1 2022 | $978,000 | +437.4% | 60,153 | +376.2% | 0.05% | +228.6% |
| Q3 2021 | $182,000 | -42.8% | 12,632 | -37.1% | 0.01% | -48.1% |
| Q2 2021 | $318,000 | +48.6% | 20,083 | -47.7% | 0.03% | -54.2% |
| Q2 2017 | $214,000 | -49.9% | 38,432 | -24.3% | 0.06% | +7.3% |
| Q1 2017 | $427,000 | +84.8% | 50,791 | +39.3% | 0.06% | +48.6% |
| Q4 2016 | $231,000 | -63.3% | 36,458 | -34.0% | 0.04% | -31.5% |
| Q3 2015 | $630,000 | -66.6% | 55,279 | -56.2% | 0.05% | -74.5% |
| Q2 2015 | $1,885,000 | +824.0% | 126,300 | +456.4% | 0.21% | +909.5% |
| Q1 2015 | $204,000 | – | 22,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |